Offer - Urjas Oil for just ₹ 1
Rheoran SF 50 Mcg/250 Mcg Rheocap is a prescription medicine that is available as a Capsule. Rheoran SF 50 Mcg/250 Mcg Rheocap also has some secondary and off-label uses. These are listed below.
The optimal dosage of Rheoran SF 50 Mcg/250 Mcg Rheocap is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Rheoran SF 50 Mcg/250 Mcg Rheocap are Shortness of Breath, Throat Irritation, Nosebleed. Some other side effects of Rheoran SF 50 Mcg/250 Mcg Rheocap have been listed ahead. Usually, these side effects of Rheoran SF 50 Mcg/250 Mcg Rheocap go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Rheoran SF 50 Mcg/250 Mcg Rheocap's effect during pregnancy is Moderate and Mild while nursing. In addition, Rheoran SF 50 Mcg/250 Mcg Rheocap's effects on the liver, heart and kidney are discussed below in the Rheoran SF 50 Mcg/250 Mcg Rheocap related warnings section.
Other conditions have been mentioned below in the Rheoran SF 50 Mcg/250 Mcg Rheocap contraindications section.
Drug interactions for Rheoran SF 50 Mcg/250 Mcg Rheocap have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Rheoran SF 50 Mcg/250 Mcg Rheocap, it is important to know that it is safe while driving, and is habit-forming.
Rheoran SF 50 Mcg/250 Mcg Rheocap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Rheoran SF 50 Mcg/250 Mcg Rheocap safe for pregnant women?
Pregnant women may experience moderate side effects from Rheoran SF. It is best to stop taking Rheoran SF immediately and inform your doctor if you notice any discomfort.
Is the use of Rheoran SF 50 Mcg/250 Mcg Rheocap safe during breastfeeding?
Rheoran SF may have very limited harmful effects for breastfeeding women.
What is the effect of Rheoran SF 50 Mcg/250 Mcg Rheocap on the Kidneys?
Rheoran SF is completely safe for kidneys.
What is the effect of Rheoran SF 50 Mcg/250 Mcg Rheocap on the Liver?
The liver can be affected by Rheoran SF. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Rheoran SF only after medical advice.
What is the effect of Rheoran SF 50 Mcg/250 Mcg Rheocap on the Heart?
You may experience side effects on your heart after taking Rheoran SF. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Rheoran SF 50 Mcg/250 Mcg Rheocap unless your doctor advises you to do so -
Is this Rheoran SF 50 Mcg/250 Mcg Rheocap habit forming or addictive?
Rheoran SF 50 Mcg/250 Mcg Rheocap does not cause addiction.
Interaction between Food and Rheoran SF 50 Mcg/250 Mcg Rheocap
Due to a lack of research, nothing can be said about the consequences of taking Rheoran SF 50 Mcg/250 Mcg Rheocap together with food.
Interaction between Alcohol and Rheoran SF 50 Mcg/250 Mcg Rheocap
No research has been done on this till date. Therefore, it is not known what the effect of taking Rheoran SF 50 Mcg/250 Mcg Rheocap with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359
